Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma
Clinical trial NCT07744750 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07744750
- Sponsor
- Changzhou No.2 People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-30
- Primary completion
- 2027-08-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.